alternatives to glp-1 medications for weight loss A new experimental weight-loss pill developed by AstraZeneca has shown promising results in a mid-stage clinical trial, helping overweight and obese adults lose up 11.8% of their body over 36 OZEMPIC: Risks, Benefits, and Natural

Onakewhor JU, Oforofuo IA, Singh SP

Rett syndrome: randomized controlled trial of L-carnitine

Halevy, S

BESN ER NDEKLER: Portakal Aromal: Deiyonize Su, L-karnitin Tartarat, Beta Alanin, Taurin, Kafein, Yeil ay Ekstresi, Sodyum Sitrat, Aroma Verici, Koruyucu: (Potasyum Sorbat, Sodyum Benzoat), Tatlandrc: Sukraloz, Krom Pikolinat

The Therapeutic Goods Administration (TGA) says that because suicidal behaviour and ideation have been reported with these relatively new GLP-1 receptor agonists, doctors should monitor patients for the emergence or worsening of depression, suicidal thoughts or behaviours, and/or any unusual changes in mood or behaviour